U.S. sales of antimicrobials for livestock increased in 2022

The U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2023 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.

The Netherlands proposes numerous actions with the National Action Plan for Antimicrobial Resistance 2024-2030.

New national action plan on antimicrobial resistance launched to protect people and animals from the risks of drug-resistant infections.

The initiative aims to provide countries with policy support and knowledge sharing to help reduce the need for antimicrobials in livestock production.

The approved standards will be submitted to the U.S. Department of Agriculture for inclusion in the regulations mandating live swine traceability.

If finalized, the rule would create for the first time a comprehensive set of regulations establishing requirements for the content and format of the labeling for new animal drugs.

The Memorandum of Understanding establishes a framework for notification, consultation, and coordination among APHIS, USDA’s General Counsel, and ENRD.

Fueled by record performances in Mexico, Central America, and Colombia, November exports of U.S. pork reached the highest value since mid-2021, according to data released by USDA and compiled by the U.S. Meat Export Federation (USMEF).

The agency’s proposal would cut the amount of nitrogen, phosphorus, and other pollutants discharged to the nation’s waters.

European countries have substantially reduced sales of veterinary antibiotics, which translates into a lower risk of bacteria becoming resistant in people and animals.

The plan provides stakeholders with a transparent roadmap of the actions that correspond to FDA’s three main veterinary stewardship goals.

The World Organisation for Animal Health (WOAH) released a landmark report showing encouraging progress in combatting antimicrobial resistance.

Sales of medically important antimicrobial drugs for use in swine were up 3% from 2020.